Adult vaccinations
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Overview
Recommendations
Recommended schedule of vaccination for adults aged 19 and older, by age group, in the United States:
| Vaccine | Age in Years | ||||
|---|---|---|---|---|---|
| 19-21 | 22-26 | 27-59 | 60-64 | >65 | |
| Influenza | 1 dose annualy | ||||
| Td/Tdap | Substitute Tdap for Td once, then give Td booster evry 10 years | ||||
| MMR | 1 or 2 doses depending on indication | ||||
| VAR | 2 doses | ||||
| HZV | 1 dose | ||||
| HPV-Female | 3 doses | ||||
| HPV-Male | 3 doses | 3 doses | |||
| PCV13 | 1 dose | 1 dose | |||
| PPSV23 | 1 or 2 doses depending on indication | 1 dose | |||
| HepA | 2 or 3 doses depending on vaccine | ||||
| HepB | 3 doses | ||||
| MenACWY or MPSV4 | 1 or 3 doses depending on indication | ||||
| MenB | 2 or 3 doses depending on vaccine | ||||
| Hib | 1 or 3 doses depending on indication | ||||
Recommended schedule of vaccination for adults aged 19 and older, by medical condition and other indications, in the United States:
| Vaccine | Pregnancy | Immunocompromised
(except HIV) |
HIV infection
CD4+ count (cells/uL) |
Asplenia, persistent
complement deficiencies |
Kidney failure,
End stage renal disease on hemodialysis |
Heart of Lung disease,
chronic alcoholism |
Chronic liver
disease |
Diabetes | Healthcare
Personnel |
Men who have
sex with men | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| <200 | >200 | ||||||||||
| Influenza | 1 dose annualy | ||||||||||
| Td/Tdap | 1 dose Tdap each pregnancy | Substitute Tdap for Td once, then Td booster every 10 years | |||||||||
| MMR | Contraindicated | 1 or 2 doses depending on indication | |||||||||
| VAR | Contraindicated | 2 doses | |||||||||
| HZV | Contraindicated | 1 dose | |||||||||
| HPV-Female | 3 doses through age 26 years | ||||||||||
| HPV-Male | 3 doses through age 26 years | 3 doses through age 21 years | 3 doses through age 26 years | ||||||||
| PCV13 | 1 dose | 1 dose | |||||||||
| PPSV23 | 1 to 3 doses depending on indication | 1 to 3 doses depending on indication | 1 to 3 doses depending on indication | ||||||||
| HepA | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | |||||||
| HepB | 3 doses | 3 doses | 3 doses | 3 doses | 3 doses | 3 doses | |||||
| MenACWY or MPSV4 | 1 or more doses depending on indication | 1 or more doses depending on indication | 1 or more doses depending on indication | ||||||||
| MenB | 2-3 doses depending on vaccine | 2-3 doses depending on vaccine | 2-3 doses depending on vaccine | ||||||||
| Hib | 3 doses post-HSCT
recipients only |
1 dose | 1 dose | 1 dose | |||||||